ArticleLeukemia research reports2025
Retreatment with brentuximab vedotin for discordant peripheral T-cell lymphomas.
Gen Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleLeukemia research reports2025
Gen Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.